Correlation Between Pyrum Innovations and PCI Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pyrum Innovations and PCI Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pyrum Innovations and PCI Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pyrum Innovations AG and PCI Biotech Holding, you can compare the effects of market volatilities on Pyrum Innovations and PCI Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pyrum Innovations with a short position of PCI Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pyrum Innovations and PCI Biotech.

Diversification Opportunities for Pyrum Innovations and PCI Biotech

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pyrum and PCI is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Pyrum Innovations AG and PCI Biotech Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PCI Biotech Holding and Pyrum Innovations is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pyrum Innovations AG are associated (or correlated) with PCI Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PCI Biotech Holding has no effect on the direction of Pyrum Innovations i.e., Pyrum Innovations and PCI Biotech go up and down completely randomly.

Pair Corralation between Pyrum Innovations and PCI Biotech

Assuming the 90 days trading horizon Pyrum Innovations AG is expected to under-perform the PCI Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Pyrum Innovations AG is 2.98 times less risky than PCI Biotech. The stock trades about -0.03 of its potential returns per unit of risk. The PCI Biotech Holding is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  219.00  in PCI Biotech Holding on September 12, 2024 and sell it today you would lose (79.00) from holding PCI Biotech Holding or give up 36.07% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pyrum Innovations AG  vs.  PCI Biotech Holding

 Performance 
       Timeline  
Pyrum Innovations 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Pyrum Innovations AG are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting basic indicators, Pyrum Innovations displayed solid returns over the last few months and may actually be approaching a breakup point.
PCI Biotech Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PCI Biotech Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's essential indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Pyrum Innovations and PCI Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pyrum Innovations and PCI Biotech

The main advantage of trading using opposite Pyrum Innovations and PCI Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pyrum Innovations position performs unexpectedly, PCI Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PCI Biotech will offset losses from the drop in PCI Biotech's long position.
The idea behind Pyrum Innovations AG and PCI Biotech Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio